Image

Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

Recruiting
18 years and older
Both
Phase 1
  • Simplified (AI rewritten)
  • Technical (Original)

This study is exploring a treatment for relapsed or refractory multiple myeloma, a type of blood cancer. The trial is testing a combination of treatments: TGFbi natural killer cells (TiNK) and isatuximab, alongside standard medications cyclophosphamide and dexamethasone. Natural killer (NK) cells are part of the immune system and can attack cancer cells. TiNK cells are specially made in a lab to improve their ability to fight cancer. Isatuximab is a type of protein called a monoclonal antibody that helps the immune system attack cancer. Cyclophosphamide and dexamethasone are chemotherapy drugs that help control cancer and reduce side effects.

  • 🌟 Study Duration: Up to 6 cycles of 28 days each, with follow-up visits after treatment.
  • đź’° Compensation: Participants may receive compensation for their time and travel.
  • 🧪 Risks: Potential side effects from the medications, monitored closely by doctors.

To join, participants must be 18 or older, have specific medical criteria, and agree to follow study guidelines. This study aims to find a safe and effective treatment for patients whose myeloma has returned or not responded to previous treatments.

Print
Study details
    Recurrent Multiple Myeloma
    Refractory Multiple Myeloma

NCT06203912

Elvira Umyarova

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.